OPPORTUNITY VALUATION

Red Team Associates assesses gaps in the market, giving clients a snapshot of the opportunity.  We develop a differentiated value proposition and can help assemble a forecast of future market potential.

Below are a few examples of life science companies and products we have valuated the opportunity.

Allegro.png

Situation

  • Developing Phase II integrin agonist (Luminate®) with multiple ophthalmic indications potential  

    • DME

    • Wet AMD

    • Dry AMD

    • Retinitis pigmentosa

Activities

  • Multiple engagements

    • Retinal surgeons​

    • Payers

    • Patients

  • Developed forecast indication market potential​

Impact

  • Helped prioritize indications

  • Provided guidance on structure of Phase III trial

  • Helped support securing of $20MM financing

Neffy.png

Situation

  • Developing intranasal version of epinephrine delivery device to replace EpiPen

  • Privately backed, brought in by Chairman

Activities

  • Assessed the value of technology in US and EU

    • Physicians – Allergists, Pediatricians, ER

    • Payers

    • Patients

    • Caregivers

    • School nurses

Impact

  • Developed initial forecast market potential 

  • Helped support securing of $20MM financing

  • Acted as Chief Marketing Officer 

Cologuard.png

Situation

  • Exact Sciences was developing Cologuard, an at-home colon cancer screening test

  • Company needed to finalize product design 

  • Needed guidance on how to address GI concerns

Activities

  • Assessed the Cologuard product

    • Physicians – Gastroenterologists

    • Payers

    • Male and female patients 

  • Developed initial go-to-market strategy

Impact

  • Helped in the design of Cologuard

    • Product

    • Delivery

    • Sensitivity/Specificity

  • Company went IPO; now market cap >$12B